Associated Papers
Disparate and shared transcriptomic signatures associated with cortical atrophy in genetic behavioral variant frontotemporal degeneration.
Shen T et al.
Molecular Neurodegeneration, 2025
Progranulin Gene Mutations in Chinese Patients with Frontotemporal Dementia: A Case Report and Literature Review.
Chu M et al.
Journal of Alzheimer's Disease : Jad, 2023
Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.
Chang A et al.
Cell, 2022
Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities.
Ruiz-Barrio I et al.
Frontiers in Neurology, 2022
Two heterozygous progranulin mutations in progressive supranuclear palsy.
Yang W et al.
Brain : a Journal of Neurology, 2021
Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.
Valdez C et al.
Human Molecular Genetics, 2020
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
Moore KM et al.
The Lancet. Neurology, 2020
Genetic predictors of survival in behavioral variant frontotemporal degeneration.
Caswell C et al.
Neurology, 2019
FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.
Mao Q et al.
Journal of Neuropathology and Experimental Neurology, 2019
A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
Hosaka T et al.
Bmc Neurology, 2017
Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.
Chiang HH et al.
European Journal of Human Genetics : Ejhg, 2013
TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
Nicholson AM et al.
Journal of Neurochemistry, 2013
Progranulin axis and recent developments in frontotemporal lobar degeneration.
Nicholson AM et al.
Alzheimer's Research & Therapy, 2012
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN.
Whitwell JL et al.
Neurology, 2011
FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
Rusina R et al.
Bmc Neurology, 2011
Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation.
Skoglund L et al.
Neurogenetics, 2009
Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update.
Gijselinck I et al.
Human Mutation, 2008
Progranulin mutation causes frontotemporal dementia in the Swedish Karolinska family.
Chiang HH et al.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2008
[Frontotemporal dementia (FTD) and genetic mutations including progranulin gene].
Arai T et al.
Rinsho Shinkeigaku = Clinical Neurology, 2008
The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.
Mackenzie IR et al.
Neurogenetics, 2007
The genetics of frontotemporal lobar degeneration.
Rademakers R et al.
Current Neurology and Neuroscience Reports, 2007
Progranulin and frontotemporal lobar degeneration.
Pickering-Brown SM
Acta Neuropathologica, 2007
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
Gass J et al.
Human Molecular Genetics, 2006
Frontotemporal Dementia in Russia: Genetic Structure, Phenotypic Diversity, and Diagnostic Biomarkers.
Shpilyukova YA et al.
Basic and Clinical Neuroscience, 0